TipRanks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market
CHM
Chimeric Therapeutics Ltd.
RESEARCH TOOLSreports
Want to see AU:CHM full AI Analyst Report?

Chimeric Therapeutics Ltd. (CHM) Income Statement

13 Followers

Chimeric Therapeutics Ltd. Income Statement

Last quarter (Q4 2026), Chimeric Therapeutics Ltd.'s total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Chimeric Therapeutics Ltd.'s net income was AU$-7.59M. See Chimeric Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 3.97MAU$ 7.46MAU$ 4.51MAU$ 2.62M
Gross Profit
AU$ 0.00AU$ 3.12MAU$ 7.45MAU$ 3.54MAU$ 1.67M
Operating Expenses
AU$ 8.36MAU$ 18.23MAU$ 19.77MAU$ 29.49MAU$ 13.62M
Depreciation and Amortization
AU$ 0.00AU$ 1.03MAU$ 1.01MAU$ 965.35KAU$ 949.76K
EBITDA
AU$ -8.36MAU$ -9.08MAU$ -11.30MAU$ -28.59MAU$ -13.62M
Operating Income
AU$ -8.36MAU$ -15.11MAU$ -12.31MAU$ -29.49MAU$ -14.57M
Other Income/Expenses
AU$ -10.43MAU$ 4.79MAU$ -3.97MAU$ -842.60KAU$ -1.16M
Pretax Income
AU$ -18.79MAU$ -10.32MAU$ -16.28MAU$ -30.33MAU$ -15.73M
Net Income
AU$ -18.81MAU$ -10.43MAU$ -12.53MAU$ -25.92MAU$ -15.90M
Per Share Metrics
Basic EPS
AU$ -0.61AU$ -0.77AU$ -1.80AU$ -5.98AU$ -4.42
Diluted EPS
AU$ -0.61AU$ -0.77AU$ -1.80AU$ -5.98AU$ -4.42
Weighted Average Shares Outstanding
 30.85M 13.52M 6.96M 4.33M 3.60M
Weighted Average Shares Outstanding (Diluted)
 30.85M 13.52M 6.96M 4.33M 3.60M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History